Last reviewed · How we verify
Paracetamol and Caffeine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Paracetamol and Caffeine (Paracetamol and Caffeine) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Paracetamol and Caffeine TARGET | Paracetamol and Caffeine | GlaxoSmithKline | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Paracetamol and Caffeine CI watch — RSS
- Paracetamol and Caffeine CI watch — Atom
- Paracetamol and Caffeine CI watch — JSON
- Paracetamol and Caffeine alone — RSS
Cite this brief
Drug Landscape (2026). Paracetamol and Caffeine — Competitive Intelligence Brief. https://druglandscape.com/ci/paracetamol-and-caffeine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab